Cleve Killingsworth resigned his post as president and CEO of Blue Cross and Blue Shield of Massachusetts. William Van Faasen, who was CEO of the company from 1992 to 2005 until he retired, will serve as interim president and CEO while the company searches for Killingsworth’s successor, company officials said in a news release. No reason was provided for Killingsworth’s departure, but it comes following financial results in February showing the company lost $149 million during fiscal 2009. The insurer also has been embroiled in a struggle with state officials over announced plans to raise premium rates on some of its policies beginning in April. Killingsworth joined the Blues plan in 2004 as president and chief operating officer and became CEO in July 2005. He later became chairman of the company’s board of directors, but in September 2009 the board voted to replace Killingsworth as chairman with director Paul Guzzi.
The New York State Health Department granted approval for 343-bed Orange Regional Medical Center, Middletown, to open a Level II, 10-bed neonatal intensive-care unit in Orange Regional’s new Wallkill facility opening in mid-2011. The new hospital will combine two existing campuses in Middletown and Goshen. Located in the hospital’s maternity unit on the sixth floor, the neonatal ICU will complement current perinatal services and full-time neonatologists offered in conjunction with 635-bed Westchester Medical Center, Valhalla, according to Orange Regional. The neonatal ICU will include a four-room maternity triage area, 12 private labor, delivery and recovery rooms, two operating rooms, 23 private, postpartum rooms, and a well-baby nursery.
Under a law enacted in New York, family members can make healthcare decisions for patients who are unable to do so and have left no instructions for their care. The Family Health Care Decisions Act allows a spouse, domestic partner, parent, adult child, sibling or close friend to determine the medical care for those who did not make their wishes known by proxy or advance directive and who cannot make their own decisions, as determined under a process outlined in the law. The law also outlines when a surrogate decisionmaker can withhold lifesustaining treatment. Patients with developmental disabilities or who live in a mental health facility are not covered under the law if other laws and regulations apply.